# Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis

> **NCT01941589** · PHASE4 · COMPLETED · sponsor: **Sheba Medical Center** · enrollment: 149 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** oral 5-ASA+/-topical 5-ASA+IV corticosteroids / PO Methylprednisolone
- **DRUG:** corticosteroids only

## Key facts

- **NCT ID:** NCT01941589
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2021-04
- **Final completion:** 2021-04
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2022-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01941589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01941589, "Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01941589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*